Elaia
VC Fund
Paris, France
Elaia is a European full stack tech and deep tech investor. We partner with ambitious entrepreneurs from inception to leadership, helping them navigate the future and the unknown. For over twenty years, we have combined deep scientific and technological expertise with decades of operational experience to back those building tomorrow. Our jointventure with Lazard, Lazard Elaia Capital, enables us to support exceptional founders at any stage. From our offices in Paris, Barcelona and Tel Aviv, we have been active partners with over 100 startups including Criteo, Mirakl, Shift Technology, AQEMIA and Alice & Bob.
- Total investments:
- 237
- Last investment:
- Lead investor:
- 46%
- Fund size:
- $154M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Elaia invests in
Stages Elaia invests in
Countries Elaia invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 15 contacts → | |||
Round size
- Seed
- $1.1M–$7.6M
- Series A
- $2.7M–$23M
- Series B
- $4.2M–$50M
Investment Focus
Industry
- Software 49 (21%)
- Artificial Intelligence 38 (16%)
- Information Technology 24 (10%)
- Health Care 18 (8%)
- SaaS 17 (7%)
Stage
- Seed 62 (26%)
- Series A 57 (24%)
- Series B 26 (11%)
- Funding Round 13 (5%)
- Pre-Seed 12 (5%)
Country
- France 94 (40%)
- United States 15 (6%)
- Spain 10 (4%)
- United Kingdom 5 (2%)
- Belgium 3 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Louisa Mesnard
CMO & Head of Sustainability
|
CMO & Head of Sustainability | Total investments: 2 | Find email | |
Philippe Gire
Partner
|
Partner | Total investments: 11 | Find email | |
Sofia Dahoune
Investment Manager
|
Investment Manager | Total investments: 5 | Find email | |
Anne-Sophie Carrese
Managing Partner
|
Managing Partner | Total investments: 16 | Find email | |
|
Céline Passedouet
Investment Director
|
Investment Director | Total investments: 7 | Find email | |
| See all 15 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Aylight
|
Aylight develops semiconductor laser and photonics platforms designed to improve optical connectivity in AI datacenters and related infrastructure. The company focuses on frequency modulated comb laser technology that generates multiple stable wavelengths from a single InP-based laser cavity. Its architecture produces an equidistant, RF-lockedwavelength grid that aligns with dense wavelength-division multiplexing requirements and reduces control complexity and power consumption. Aylight targets use cases in AI datacenter interconnects, quantum computing hardware, precision metrology, and communication equipment. Its products aim to integrate with terabit optical links and wavelength-division multiplexing systems while remaining compatible with existing fabrication processes. | $5.1M / Pre-Seed / Jul 06, 2026 | |
MyC
|
MyC is a workforce health platform that unifies employee health data and automates compliance across organizations. The platform emphasizes the transition from traditional medical systems to digital solutions, enhancing operational efficiency and data management for medical centers. MyC facilitates the integration of medical equipment and deviceswith digital medical records to ensure automated and seamless data flow. | $11.8M / Series A / Feb 03, 2026 | |
Linkup
|
Linkup connects large language models (LLMs) and AI agents to the internet. The platform enables AI systems to access, search, and interact with web content efficiently, enhancing their capabilities and reducing inaccuracies. By providing APIs, Linkup allows developers to integrate web content into AI applications seamlessly. | $10M / Seed / Feb 02, 2026 | |
Aviwell
|
Aviwell’s mission is to develop healthy, native, natural, and sustainable solutions to improve animal health and growth to better nourish the planet ... At a fraction of the cost. | $12.9M / Series A / Jan 23, 2026 | |
Enodia Therapeutics
|
Enodia Therapeutics is a biotech company that provides transforming treatments for cancer, inflammation, and viral infection diseases. | $24.2M / Seed / Jan 08, 2026 | |
Sim&Cure
|
Sim&Cure is the first company to be cleared to market a patient-based simulation model for aneurysm treatment that allows prediction of the deployment of medical devices (flow diverter, intrasaccular device, laser-cuter stent). Sim&Size® simulates each size and type of device according to the patient’s unique anatomy in order to provideessential information prior to the choice of sizing. | $11.6M / Series A / Nov 28, 2025 | |
NcodiN
|
NcodiN develops nanophotonic chips for data transport for processors that improves speed, energy efficiency and heating of the circuit | $18.5M / Seed / Nov 20, 2025 | |
GetVocal AI
|
GetVocal AI is help companies automate customer service processes with the most advanced Conversational AI phone agent. | $26M / Series A / Nov 18, 2025 | |
Hummink
|
Hummink develops additive manufacturing technology designed to provide tools to design and manufacture at the nanoscale.It uses a patented technology that combines a nanometric pen with an oscillating microresonator to perform a capillary deposition of various liquids, thereby providing semiconductor molecular diagnostic industries with the toolsto build large objects with the same resolution and precision on millimetric to centimetric substrates.Amin M'barki, Pascal Boncenne, Lydéric Bocquet, Alessandro Siria, Antoine Nigues established the company in Paris, Île-de-France in 2020. | $17.4M / Series A / Nov 17, 2025 | |
mimic
|
mimic provides a flexible and intuitive answer to labor shortages worldwide, by building and deploying robots that fit seamlessly into human workplaces. Their scalable foundation AI model enables truly dexterous robotic manipulation by learning directly from human data. | $16M / Seed / Nov 03, 2025 | |
| See all 237 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Elaia invest in?
Elaia invests primarily in Software, Artificial Intelligence and Information Technology startups, most often at Seed and Series A stage. Most of the 237 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Elaia's check size?
Elaia typically joins rounds of $1.1M–$7.6M at Seed, $2.7M–$23M at Series A and $4.2M–$50M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Elaia participates in.
How do I contact Elaia?
Public channels for Elaia include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Elaia?
The team at Elaia includes Louisa Mesnard (CMO & Head of Sustainability), Philippe Gire (Partner) and Sofia Dahoune (Investment Manager), among 15 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
